Morpho Alfasigma Capabilities Update October 2026: Small Molecule Drug Product

Bringing small molecule drug products from development to commercialization requires a seamless combination of scientific expertise, manufacturing excellence and regulatory support. This presentation will highlight how Morpho, Alfasigma’s Contract Development and Manufacturing Organization (CDMO), supports pharmaceutical and biotech partners throughout the entire product lifecycle, from formulation development and process optimization to clinical supply and commercial manufacturing.

Attendees will gain an overview of Morpho’s integrated development and manufacturing capabilities, including formulation and analytical development, technology transfer, scale-up, clinical trial material production and commercial supply. The presentation will also showcase the complementary roles of Morpho’s development and manufacturing sites in Italy, enabling efficient progression from early-stage development through large-scale commercial production.

By combining scientific expertise, operational excellence and a customer-centric approach, Morpho helps partners overcome development challenges, accelerate timelines, and ensure reliable product delivery while maintaining the highest quality and regulatory standards.